Viking Therapeutics, Inc. (VKTX) Social Stream
VIKING THERAPEUTICS INC (VKTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VKTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 9 | $28 | $12 | $18.666 | $21.03 | -11.24% |
| 2022-01-27 | 9 | $28 | $12 | $18.25 | $21.03 | -13.22% |
| 2022-02-10 | 9 | $28 | $10 | $17.875 | $21.03 | -15% |
| 2022-04-08 | 9 | $28 | $10 | $17.375 | $21.03 | -17.38% |
| 2022-04-28 | 9 | $28 | $10 | $16 | $21.03 | -23.92% |
| 2022-07-28 | 9 | $28 | $10 | $15.428 | $21.03 | -26.64% |
| 2022-10-10 | 8 | $28 | $10 | $15.428 | $21.03 | -26.64% |
| 2022-10-27 | 8 | $28 | $10 | $15.285 | $21.03 | -27.32% |
| 2022-12-20 | 8 | $28 | $10 | $15.714 | $21.03 | -25.28% |
| 2023-01-06 | 8 | $28 | $11 | $16.428 | $21.03 | -21.88% |
| 2023-02-08 | 8 | $28 | $11 | $16.714 | $21.03 | -20.52% |
| 2023-02-13 | 8 | $28 | $12 | $17.142 | $21.03 | -18.49% |
| 2023-02-23 | 8 | $28 | $12 | $17.571 | $21.03 | -16.45% |
| 2023-03-16 | 10 | $28 | $12 | $18.125 | $21.03 | -13.81% |
| 2023-03-29 | 9 | $35 | $19 | $26.777 | $21.03 | 27.33% |
| 2023-04-06 | 10 | $35 | $19 | $26.777 | $21.03 | 27.33% |
| 2023-04-25 | 10 | $35 | $19 | $27.333 | $21.03 | 29.97% |
| 2023-04-27 | 10 | $35 | $19 | $28.666 | $21.03 | 36.31% |
| 2023-05-08 | 10 | $35 | $23 | $29.222 | $21.03 | 38.95% |
| 2023-05-16 | 10 | $40 | $25 | $32.625 | $21.03 | 55.14% |
| 2023-05-31 | 10 | $40 | $25 | $32.555 | $21.03 | 54.8% |
| 2023-11-09 | 10 | $40 | $28 | $33.666 | $21.03 | 60.09% |
The Trend in the Analyst Price Target
VKTX's average price target has moved up $13.77 over the prior 26 months.
VKTX reports an average of 104.92% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-06 | 10 | 35 | 19 | 26.777 | 16.68 | 60.53% |
| 2023-04-27 | 10 | 35 | 19 | 28.666 | 19.61 | 46.18% |
| 2023-05-08 | 10 | 35 | 23 | 29.222 | 22.86 | 27.83% |
| 2023-08-08 | 10 | 40 | 28 | 33.666 | 14.22 | 136.75% |
| 2023-08-10 | 10 | 40 | 28 | 33.666 | 14.88 | 126.25% |
VKTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.1 | 9 | 1 | 0 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
VKTX's average broker recommendation rating worsened by 0.11 over the prior 44 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- VIKING THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 807.92% of all US stocks.
- In terms of how VIKING THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 2624.14% of that group.
- In the context of stocks in the small market cap category, VIKING THERAPEUTICS INC's variance in analysts' estimates is lower than -1983.58% of them.
- VKTX has a higher average analyst price target than 1012.08% of Healthcare stocks.
Stocks similar to VIKING THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are COLL, RDHL, and KMDA.
View All Top Stocks by Price Target
What is the outlook for VKTX? Use POWR Ratings for clearer insight into price direction.